[1]
“RISK-BASED APPROACHES IN GLOBAL REGULATORY SUBMISSIONS FOR RARE DISEASES”, Ind-Am. J Pharm. Bio. Sci., vol. 21, no. 3, pp. 10–20, Aug. 2023, Accessed: Apr. 17, 2026. [Online]. Available: https://iajpb.org/index.php/iajpb/article/view/172